SCHEMBL6820686

SCHEMBL6820686

Nc1ccc2c(=O)c(C(=O)O)cn(C3CC3)c2n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.49
KDM4E B2RXH2 3/20 0.48
TOP2A P11388 8/20 0.45
TOP2B Q02880 8/20 0.45
CHRM2 P08172 1/20 0.43
DRD1 P21728 1/20 0.43
LMNA P02545 3/20 0.42
ABCC4 O15439 2/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
PTGS1 P23219 1/20 0.42
KMT2A Q03164 1/20 0.42
KCNH2 Q12809 2/20 0.41
GSK3B P49841 1/20 0.41
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7578567 0.87 KDM4E (0.48) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL10562097 0.84 LMNA (0.61) DPP4KDM4ETOP2ATOP2BLMNA
SCHEMBL10994928 0.81 DHFR (0.48) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL10747566 0.80 KDM4E (0.47) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL10559283 0.80 LMNA (0.58) KDM4ETOP2ATOP2BLMNAABCC4
SCHEMBL10876232 0.79 DPP4 (0.59) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL2617022 0.78 CHRM2 (0.53) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL10743308 0.77 CSF1R (0.47) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL10501993 0.77 KDM4E (0.54) DPP4KDM4ETOP2ATOP2BCHRM2
SCHEMBL7960307 0.77 KDM4E (0.55) DPP4KDM4ETOP2ATOP2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763359-A1 Pharmaceutical composition for topical use R.R.A. S.r.l. (IT) 1997-03-19 EP claimed
EP-0049355-B1 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridine or quinoline)-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them BAYER AG (DE) 1984-10-10 EP claimed
US-20040082593-A1 Infusion of ciprofloxacin having reduced acid content and being stable in storage FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2004-04-29 US disclosed
EP-0763359-A1 Pharmaceutical composition for topical use R.R.A. S.r.l. (IT) 1997-03-19 EP disclosed
EP-0763359-A1 Pharmaceutical composition for topical use R.R.A. S.r.l. (IT) 1997-03-19 EP disclosed
US-5077429-A 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-QUINOLINE- AND NAPHTHYRIDINE-3-CARBOXYLIC ACIDS, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THESE COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 1991-12-31 US disclosed
EP-0153828-B1 1-CYCLOPROPYL-1, 4-DIHYDRO-6-FLUORO-4-OXO-1, 8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDS; THEIR DERIVATIVES AND A PROCESS FOR PREPARING THE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1990-12-27 EP disclosed
US-4762844-A ANIMAL GROWTH REGULATORS BAYER AKTIENGESELLSCHAFT (DE) 1988-08-09 US disclosed
US-4670444-A 7-amino-1-cyclopropyl-4-oxo-1, 4-dihydro-quinoline-and naphthyridine-3-carboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1987-06-02 US disclosed
US-4620007-A BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1986-10-28 US disclosed
EP-0049355-A1 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridine or quinoline)-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them BAYER AG (DE) 1982-04-14 EP disclosed